The role of oxidative stress (OXS) due to myocardial nitric oxide synthase (NOS) uncoupling related to oxidative depletion of its cofactor tetrahydrobiopterin (BH 4 ) emerged in the pathogenesis of heart failure with preserved ejection fraction (HFPEF).
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Introduction
Hypertension is the most common underlying cause of heart failure with preserved ejection fraction (HFPEF), which partly or entirely accounts for 78-88% of HFPEF cases [1] [2] [3] .
The transition of hypertensive heart disease to HFPEF is characterized by progressive left ventricular (LV) hypertrophy and deterioration of LV diastolic and atrial function 4 . Oxidative stress (OXS) mainly due to myocardial nitric oxide synthase (NOS) uncoupling as a consequence of the depletion of the NOS cofactor tetrahydrobiopterin (BH 4 ) may play a decisive role in this transition process [5] [6] [7] [8] .
Both essential hypertension and LV diastolic dysfunction, the latter is considered the main pathophysiologic mechanism of HFPEF, are partly determined genetically by a large number of genes, each exerting only a small effect 9, 10 . Thirty 11 or 30-60 % 12 of blood pressure variation can also be attributed to genetic influences, and environmental exposures account for the remaining 40-70%.
In this study we sought to investigate gene polymorphisms related to both hypertension or endothelial dysfunction and OXS or BH 4 metabolism in order to assess whether there is a genetic predisposition to OXS in patients with hypertension and normal ejection fraction (EF), and if yes, how it is associated with LV diastolic dysfunction in these patients. To this end, we determined the prevalence of 6 single nucleotide polymorphisms (SNPs) of genes encoding enzymes related to OXS, BH 4 metabolism and NOS function. The prevalence of 4 SNPs (rs841 C>T, rs3783641 A>T, rs10483639 C>G and rs8007267 G>A) of guanosine triphosphate cyclohydrolase-1 (GTPCH-1), the rate limiting enzyme in BH 4 synthesis, 1 (rs4880 T>C) of manganese superoxide dismutase (MnSOD) and 1 (rs1799983 G>T) of endothelial NOS (NOS3) genes were determined.
The studied 4 GTPCH-1 SNPs are strongly linked to each other and later it was referred as the "pain-protective" GTPCH-1 haplotype 13 . The minor alleles of these SNPs are associated with reduced pain sensitivity, mildly increased blood pressure and heart rate due to decreased BH 4 production [and consequential decreased nitric oxide-mediated endothelial function and increased vascular superoxide anion radical (O 2 -. ) production], which mainly manifests in pathophysiological situations when BH 4 production would be normally increased due to upregulation of GTPCH-1, e. g. at inflammatory sites or in injured neurons 13 or in blood vessels exposed to high blood pressure, high cholesterol or other cellular stress factors 13 .
Manganese superoxide dismutase (MnSOD) encoded by SOD2 gene is an enzyme catalyzing dismutation of O 2 -. to hydrogen peroxide and is an important substituent of cellular enzymatic antioxidant defense against OXS 14 . MnSOD proved to be essential for the survival of aerobic organisms, demonstrated by the extremely short survival of MnSOD knockout mice, which died shortly after birth with dilated cardiomyopathy and neurodegeneration 14 .
The extensively investigated rs4880 SNP (T>C change at nucleotide level) causes a substitution of valine (GTT) with alanine (GCT) at codon 16. The alanine variant of MnSOD has an α-helical mitochondrial targeting domain, whereas the valine variant of MnSOD has a β-pleated sheet conformation [14] [15] [16] . This conformational difference results in a more efficient transport of alanine variant of MnSOD into mitochondria than the valine variant [14] [15] [16] , which results in a more efficient protection against OXS. The homozygote Ala/Ala genotype has a 30-40% higher MnSOD activity than its Val/Val counterpart [14] [15] [16] . The alanine variant is associated with decreased risk for coronary artery disease, myocardial infarction and atherosclerosis, whereas the Val/Val genotype is an independent genetic risk factor for coronary artery disease and vasospastic angina [15] [16] [17] . variant has an enhanced susceptibility to intracellular proteolytic cleavage compared with the 298Glu variant, and has been associated with a lower eNOS activity and reduced generation of NO 18, 19 . However, other studies have not confirmed these associations 20 . The minor allele variant of the rs1799983 G>T SNP of NOS3 gene may be associated with endothelial dysfunction and increased risk for coronary artery disease [21] [22] [23] .
Materials and Methods
Patients
The Exclusion criteria included diabetes mellitus, more than a mild degree valvular or congenital heart disease, the presence of electrical pacemakers or implantable cardiac defibrillators, prior cardiovascular surgery, an established history of coronary heart disease, prior or ongoing atrial tachyarrhythmias, prior or manifest heart failure, any malignant or immunological disease, anticoagulant or antioxidant treatment, or conditions associated with acute inflammation or stress.
Measurement of oxidative stress parameters
All measurements were carried out from plasma samples. Protein carbonylation (PC) assays were based on the photometric method of Levine et al. 4 to biopterin and the alkaline-stable oxidized biopterin level (BH 2 plus biopterin) obtained using alkaline iodine, which oxidizes only BH 2 to biopterin. These methods were described in a more detailed way earlier 27 .
Molecular biology methods
The total genomic DNA was isolated from peripheral blood using a QIAamp DNA Blood
Mini Kit (QiagenGmbH, Hilden, Germany), DNA Isolation Kit for Mammalian Blood (Roche, Mannheim, Germany; Indianapolis, IN, USA). Genotypes for the rs841, rs3783641, rs10483639, rs8007267, rs4880 and rs1799983 polymorphisms were determined using a predesigned Taqman allelic discrimination assay (C_9866639_10, C_25800745_10, C_30444867_20, C_1545138_10, C_8709053_10 and C_3219460_20 respectively). The assay was carried out according to the manufacturer's instructions (Applied Biosystems, Applied Biosystems Group, 850 Lincoln Center Drive, Foster City, CA) on a 7500 Fast Real Time PCR System (Applied Biosystems).
Calculation of minor allele frequency and genetic score
Minor allele frequency (MAF) was calculated by dividing the total number of minor alleles by the total number of alleles in each group.
We devised a genetic score based on the MAFs of the investigated SNPs indicating the predisposition of patients to OXS. The calculation of the genetic score was based on the total number of minor alleles in each subject. In the case of rs1799983 NOS3 SNP the presence of minor allele predisposes to OXS, therefore the homozygotes of each major allele received a score 0, each minor allele heterozygotes received a score 1 and each minor allele homozygotes received a score 2. In the case of rs4880 MnSOD SNP, as the presence of minor allele is protective against OXS, an inverse score was used: major allele homozygotes received a score 2, minor allele heterozygotes received a score 1 and minor allele homozygotes received a score 0. Since the inheritance of the 4 GTPCH-1 SNPs are strongly linked, and 2 haplotypes are representing 91% of the patients, therefore we calculated a haplo4 score the following way: if the number of GTPCH-1 minor alleles was 0 or 1 the score was 0, if the number of GTPCH-1 minor alleles was >2, the score was 1. Thus, theoretically the total value of the genetic score could have ranged from 0 to 5. Patients were divided into two groups according to the total value of the genetic score: 1.) patients with low genetic risk for OXS with a total genetic score value of 0 or 1; and 2.) patients with high genetic risk for OXS with a total genetic score value of >2. This definition of patients with low and high genetic risk for OXS is somewhat arbitrary, however our precalculations using other definitions as well showed that this definition could best demonstrate the between-groups difference in genetic risk for increased OXS.
Echocardiography
Standard echocardiography
Echocardiographic imaging was carried out using a Philips iE33 system (Philips 
Statistical analysis
All variables are expressed as mean+SD.
One-way analysis of variance (ANOVA) was used for comparisons of patient characteristics as well as of oxidative stress and LV mass parameters followed by 
Results
Patient characteristics
Hypertensive patients with (HTDD+) or without LV diastolic dysfunction (HTDD-)
and healthy controls had similar gender distribution, height, body weight, body surface area, diastolic blood pressure, heart rate, estimated glomerular filtration rate, HDL-cholesterol and hemoglobin concentrations. Medication was similar in the two hypertensive groups (Table 1) .
There was no difference in age between the control and the whole hypertensive patient group (66.1+4.4 vs. 69.4+7.7 years, the latter data are not shown in Table 1 ), however, patients in the HTDD+ group were slightly older than those in the control and HTDD-groups. The body mass index (BMI) was higher and the systolic blood pressure was similarly elevated in both patient groups vs. the control group. The serum creatinine value was higher in the HTDD+ group compared with the control group ( Table 1 ). The LDL-cholesterol was decreased in a borderline significant (p=0.0558) fashion in the HTDD-group and significantly in the HTDD+ group compared with controls, probably due to the fact that greater number of patients received statins in the hypertensive groups. The systolic blood pressure was similarly elevated in both patient groups vs. the control group (Table 1) .
LV diastolic dysfunction
At the baseline examination LV diastolic dysfunction was not found in 38/94(40%) of patients with hypertension and normal EF (HTDD-group) and 56/94(60%) patients had mild, Grade 1 (54 patients) or Grade 1a (2 patients) LV diastolic dysfunction (HTDD+ group).
LV mass
LV mass (LVM) increased in the HTDD+ group compared with the control and HTDD-groups, while LVM was similar in the HTDD-and control groups. LVM/body surface area (BSA) increased in both patient groups versus the controls, and in the HTDD+ group versus the HTDD-group. LVM/BMI increased in the HTDD+ group versus the controls and in a borderline significant manner (p=0.063) in the HTDD+ versus the HTDDgroup (Table 2) 27 .
Association of the investigated individual gene polymorphisms with hypertension and LV diastolic dysfunction
Minor allele frequency distribution After all 6 SNPs were assessed, we confirmed that all alleles were in Hardy-Weinberg equilibrium. In none of the investigated individual SNPs a significant between-groups difference in MAFs was found (Table 3 )
GTPCH-1 Haplotype analysis
Our linkage disequilibrium analysis (these data are not shown) demonstrated a strong linkage among all four tested GTPCH SNPs according to the results published by Doehring A. et al. 13 and to the data of the latest HapMap database.
Combined effect of oxidative stress and BH4 metabolism associated SNPs on hypertension and LV diastolic dysfunction
As it was expected, none of the investigated individual SNPs had significantly different MAF compared with controls and was significantly associated with hypertension and LV diastolic dysfunction. Therefore, we devised a genetic score based on the total number of minor alleles of the investigated SNPs in each subject characterizing predisposition to OXS.
The distribution of genetic score in different groups is shown in Table 4 p=0.035). Patients with a high genetic score showed only a trend for increased risk for hypertension without LV diastolic dysfunction (Table 5) .
Protein carbonylation and plasma BH 4 and total biopterin levels
Compared with the controls protein carbonylation (PC) and plasma BH 4 levels were increased both in the HTDD-and HTDD+ groups and the plasma total biopterin (=BH 4 +BH 2 +biopterin) level was increased in the HTDD+ group (Table 2) .
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Discussion
Main findings
In this study we demonstrated that in patients with hypertension and normal EF there may be a genetic predisposition to OXS, which increases in line with the presence of LV diastolic dysfunction even after adjustment for age, gender, smoking habits, obesity, HDL and LDL-cholesterol levels and glomerular filtration rate in multiple logistic regression analysis.
LV mass in itself or indexed to BSA or BMI increased in parallel with the presence of LV diastolic dysfunction in our patients as well. Since the development of LV diastolic dysfunction and hypertrophy are important markers of the transition of hypertensive heart disease to HFPEF 4 our results suggest that the greater number of prooxidant alleles is present in a subject with hypertension, the greater might be the likelihood of the transition of hypertensive heart disease to HFPEF. In fact, we verified the presence of OXS in patients with hypertension and normal EF by the measurement of increased protein carbonylation and increased plasma BH 4 and total biopterin levels 27 . Increased plasma BH 4 and total biopterin might suggest OXS is due to myocardial NOS uncoupling, because there is some evidence that increased plasma BH 4 level is associated with decreased vascular (and probably tissue) BH 4 level 7, 8 , which causes NOS uncoupling, and in animal models of HFPEF myocardial NOS uncoupling as the most likely source of OXS was elegantly verified 5, 6 . To the best of our knowledge so far only the single nucleotide polymorphisms of individual genes encoding enzymes related to OXS were studied in hypertensive patients and this is the first study with the aim to investigate the genetic predisposition of hypertensive patients to OXS.
The rationale behind the selection of investigated gene polymorphisms
The common feature of all investigated gene polymorphisms in this study was that they have been related to both endothelial dysfunction or hypertension and OXS and the For any multigenic disorder it is always a problem to quantify the importance of certain genetic variants on the phenotype. Our genetic score is a simplified model for quantitative trait heritance. Our model characterized well the associated phenotype and may be a useful marker in the prediction of progression of LV diastolic dysfunction and transition of hypertensive heart disease to HFPEF.
Limitations
In this study we tested only a few (six) SNPs that might be related to increased OXS, however the regulation of redox metabolism, the production and elimination of free radicals in cells is a far more complicated process, involving much more proteins and enzymes encoded by several genes.
Although we verified a genetic predisposition in patients with hypertension and normal EF to OXS in line with the presence of their LV diastolic dysfunction, the exact pathophysiological mechanisms of this genetic predisposition and whether the increased genetic risk for OXS plays an important role in the transition of hypertensive heart disease to HFPEF remain to be clarified in further future studies.
Statins and other drugs, such as renin-angiotensin system inhibitors and beta blockers, used in the treatment of hypertension might have decreased OXS in patients with hypertension compared to controls due to their antioxidant effect 34, 35 .
Another significant limitations of this study are the small sample size, especially in the control group, and the lack of a verification cohort, therefore these preliminary results need further verification in a greater patient population with the application of a separate verification cohort.
Conclusions
We verified an increased OXS in hypertensive patients with normal LVEF, a potential precursor condition of HFPEF, which may be partly genetically determined. A high genetic risk of OXS was significantly associated with the presence of LV diastolic dysfunction even after adjustment for confounding variables. The genetic score devised to indicate predisposition to OXS, which was based on the MAFs of 6 investigated SNPs of genes encoding enzymes related to OXS, BH 4 metabolism and NOS function, together with LV diastolic dysfunction, LVM and atrial dysfunction might be a useful marker of the transition of hypertensive heart disease to HFPEF. 
